Form 4: Channel Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Matthew Pauls, a Director of Channel Therapeutics Corp, sold 786 shares of common stock on October 2, 2026 for $21.00 per share.
Summary
- Open-market sale: disposed of 786 Common Stock at $21.00 ($16,506) on October 2, 2026; holds 13,578 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $16,506 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Matthew Pauls — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Common Stock | 786 | $21 | $16.5K | 13,578 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (786 shares) |
Keywords
insider transaction, Form 4, PTHS, Pelthos Therapeutics Inc., bearish, Matthew Pauls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.